Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
med-mastodon.com is one of the many independent Mastodon servers you can use to participate in the fediverse.
Medical community on Mastodon

Administered by:

Server stats:

389
active users

med-mastodon.com: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.8

Erika Hamilton, MD

RT @Sameh_VuMedi@twitter.com

Dr. Erika Hamilton @ErikaHamilton9@twitter.com @SarahCannonDocs@twitter.com discussing Dose-Expansion Study DESTINY-Breast07: T-DXd as Monotherapy or Combined With in pts With Metastatic + from

bit.ly/SABCS22TDX

🐦🔗: twitter.com/Sameh_VuMedi/statu

VuMediSABCS 2022 Dose-Expansion Study DESTINY-Breast07: T-DXd as Monotherapy or Combined With Pertuzumab in Patients With Metastatic HER2+ BCSABCS 2022 Dose-Expansion Study DESTINY-Breast07: T-DXd as Monotherapy or Combined With Pertuzumab in Patients With Metastatic HER2+ BC
Dec 22, 2022, 05:07 PM·Quiet public·Mastodon Twitter Crossposter
0boosts·0favorites
ExploreLive feeds
About